What is NDC 51754-0204?

51754-0204 is the product NDC for Verapamil Hydrochloride, Verapamil hydrochloride 2.5 mg/mL injection, listed with the FDA by EXELA PHARMA SCIENCES, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.

EXELA PHARMA SCIENCES, LLC, NDC labeler code 51754. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Verapamil Hydrochloride?

131 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Verapamil Hydrochloride NDC 51754-0204

NDC codes

FDA NDC Directory

Product NDC (as listed)51754-0204Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51754-0204Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
51754-0204-2	5175402040251754020402	5 VIAL in 1 CARTON (51754-0204-2) / 2 mL in 1 VIALMarketed from Feb 1, 2017
51754-0204-4	5175402040451754020404	25 VIAL in 1 CARTON (51754-0204-4) / 2 mL in 1 VIALMarketed from Feb 1, 2017

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Verapamil Hydrochloride
Generic name (nonproprietary): verapamil hydrochloride
Active ingredients: Verapamil hydrochloride — 2.5 mg/mL
Dosage form: Injection
Route: Intravenous
Labeler: EXELA PHARMA SCIENCES, LLCNDC labeler code 51754
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 018925
Marketing start: Feb 1, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 51754-0204_f1a97533-a1b0-4b0e-b4c2-76d5bee9b4e2SPL ID f1a97533-a1b0-4b0e-b4c2-76d5bee9b4e2SPL set ID 3318e357-0660-44f4-8170-91a51bd762fbRxCUI 1665057UNII V3888OEY5R
Pharmacologic class: Calcium Channel Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N451754020402 followed by a unit qualifier and the quantity

Package 51754-0204-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 23, 2017.

Indications (excerpt from the label)

INDICATIONS AND USAGE Verapamil is indicated for the treatment of supraventricular tachyarrhythmias, including: Rapid conversion to sinus rhythm of paroxysmal supraventricular tachycardias, including those associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] syndromes). When clinically advisable, appropriate vagal maneuvers (e.g., Valsalva maneuver) should be attempted prior to Verapamil administration. Temporary control of rapid ventricular rate in atrial flutter or atrial fibrillation, except when the atrial flutter and/or atrial fibrillation are associated with accessory bypass tracts (Wolff-Parkinson-White [WPW] and Lown-Ganong-Levine [LGL] sy…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 51754-0204

What is NDC 51754-0204?: 51754-0204 is the product NDC for Verapamil Hydrochloride, Verapamil hydrochloride 2.5 mg/mL injection, listed with the FDA by EXELA PHARMA SCIENCES, LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Verapamil Hydrochloride.
What is the active ingredient?: Verapamil hydrochloride.
Who is the labeler?: EXELA PHARMA SCIENCES, LLC, NDC labeler code 51754. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Verapamil Hydrochloride?: 131 other product NDCs are listed under this name. See all Verapamil Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Verapamil Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Verapamil hydrochloride	Verapamil hydrochloride 120 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1953	70771-1953-0170771-1953-05
Verapamil hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1954	70771-1954-0170771-1954-05
Verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1955	70771-1955-0170771-1955-05
Verapamil hydrochloride	Verapamil hydrochloride 120 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-561	68382-0561-0168382-0561-05
Verapamil hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-562	68382-0562-0168382-0562-05
Verapamil hydrochloride	Verapamil hydrochloride 240 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-563	68382-0563-0168382-0563-05
Verapamil Hydrochloride	Verapamil hydrochloride 120 mg/1	Capsule, Extended releaseOral	Safecor Health LLC	48433-145	48433-0145-20
Verapamil Hydrochloride	Verapamil hydrochloride 180 mg/1	TabletOral	REMEDYREPACK INC.	70518-4513	70518-4513-00
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	REMEDYREPACK INC.	70518-4453	70518-4453-00
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	Injection, SolutionIntravenous	Caplin Steriles Limited	65145-114	65145-0114-05

All 132 Verapamil Hydrochloride NDCs

Other NDCs under NDA 018925

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 018925
Product	Strength	Form · route	Labeler	Product NDC
Verapamil Hci	Verapamil hydrochloride 2.5 mg/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1442
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	InjectionIntravenous	EXELA PHARMA SCIENCES, LLC	51754-0203
Verapamil Hydrochloride	Verapamil hydrochloride 2.5 mg/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7048